ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Abstract: PUB332

Renal Riddles: Decoding a Case of Lupus Nephritis

Session Information

Category: Glomerular Diseases

  • 1402 Glomerular Diseases: Clinical, Outcomes, and Therapeutics

Authors

  • Chennupati, Karteek, Texas Health Harris Methodist Hospital Fort Worth, Fort Worth, Texas, United States
  • Vo, Russell, Texas Health Harris Methodist Hospital Fort Worth, Fort Worth, Texas, United States
  • Abarca Jr, Leonel, Texas Health Harris Methodist Hospital Fort Worth, Fort Worth, Texas, United States
  • Fairweather, Morgan G., Texas Health Harris Methodist Hospital Fort Worth, Fort Worth, Texas, United States
Introduction

Systemic lupus erythematosus (SLE) is characterized by the production of autoantibodies resulting in immune-mediated injury often involving multiple organs. Current literature suggests that anti-dsDNA antibodies facilitate the pathogenesis of the disease process. However, the absence of anti-dsDNA antibodies cannot exclude the diagnosis of lupus as up to 15 to 35% of individuals with lupus test negative.

Case Description

24-year-old male presented with diffuse swelling and hypertensive urgency refractory to recent initiation of anti-hypertensives. Physical exam revealed a discoid, hypopigmented rash on both shoulders, non-scarring alopecia areata, and anasarca. Work-up revealed nephrotic range proteinuria, elevated Scr, and hypoalbuminemia. ANA 1:160, low C3 and C4, negative anti-dsDNA antibodies, and positive anti-Smith antibodies. Renal biopsy showed an abundance of immune complex deposits on electron microscopy consistent with class V lupus nephritis. The patient was initiated on high-dose steroids, mycophenolate mofetil, hydroxychloroquine, and atovaquone and discharged with outpatient follow-up.

Discussion

Lupus nephritis is a secondary membranous nephropathy caused by the deposition of immune complexes derived from anti-dsDNA antibodies throughout the glomeruli. Depending on the test used, the specificity for anti-dsDNA antibodies ranges from 80 to 97%. Studies suggest that the presence of anti-Smith antibodies correlates with younger age of onset, higher rates of alopecia, and transaminitis. Male gender is associated with higher mortality rates as compared with female patients with similar baseline features and treatment. Renal involvement in SLE patients poses a higher mortality rate in cases presenting with acute kidney injury and those that fail to achieve remission at 1 year.

Physical Exam Findings in Lupus Nephritis Patients (N=300)
Lupus Specific Findings:
Malar rash
Photosensitive dermatitis
Generalized maculopapular rash
Discoid rash
80%
50%
26.67%
20%
Lupus non-specific findings
Non-scarring alopecia
Oral ulcers
Vasculitic lesions
Raynauds phenomenon
86.67%
56.67%
33.34%
6.67%

Renal Biopsy
1A: EM, 1800X with multiple immune complex deposits
1B: EM, 4400X uranyl acetate staining multiple immune complex deposits and effacement of podocytes.